Related references
Note: Only part of the references are listed.New Therapeutics for Hepatitis B: The Road to Cure
Susanna Naggie et al.
ANNUAL REVIEW OF MEDICINE, VOL 72, 2021 (2021)
The Mechanisms of HBV-Induced Hepatocellular Carcinoma
Yu Jiang et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Liana Fraenkel et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Glucocorticoids in T cell development, differentiation and function
Matthew D. Taves et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription
Debora Salerno et al.
GUT (2020)
Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases
Rowan S. Hardy et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Hepatitis B Virus Reactivation Potentiated by Biologics
Eiichi Ogawa et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2020)
Mitomycin, 5-fluorouracil, leflunomide, and mycophenolic acid directly promote hepatitis B virus replication and expression in vitro
Jie Ruan et al.
VIROLOGY JOURNAL (2020)
Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations
Christos Koutsianas et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2020)
Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis
Masayoshi Harigai et al.
RMD OPEN (2020)
Risk-stratified management strategies for HBV reactivation in RA patients receiving biological and targeted therapy: A narrative review
Yi-Ming Chen et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2019)
Methotrexate mechanism in treatment of rheumatoid arthritis
Benjamin Friedman et al.
JOINT BONE SPINE (2019)
Impact of dose and duration of corticosteroid on the risk of hepatitis flare in patients with chronic hepatitis B
Grace Lai-Hung Wong et al.
LIVER INTERNATIONAL (2019)
Abatacept modulates CD80 and CD86 expression and memory formation in human B-cells
Raquel Lorenzetti et al.
JOURNAL OF AUTOIMMUNITY (2019)
HBV-Induced Immune Imbalance in the Development of HCC
Yongyan Chen et al.
FRONTIERS IN IMMUNOLOGY (2019)
Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection
Adam J. Gehring et al.
GASTROENTEROLOGY (2019)
Increased risk of hepatitis B virus reactivation in systemic lupus erythematosus patients receiving immunosuppressants: a retrospective cohort study
W. T. Lin et al.
LUPUS (2018)
Safety Profile of Secukinumab in Treatment of Patients with Psoriasis and Concurrent Hepatitis B or C: A Multicentric Prospective Cohort Study
Hsien-Yi Chiu et al.
ACTA DERMATO-VENEREOLOGICA (2018)
Risk of Hepatitis B Reactivation in Patients with Psoriasis on Ustekinumab
Sze-Wen Ting et al.
CLINICAL DRUG INVESTIGATION (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate-to-severe psoriasis through 5years of treatment (SCULPTURE Extension Study)
R. Bissonnette et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Therapeutic Mechanisms of Glucocorticoids
Jolien Vandewalle et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2018)
The prevalence and risk factors of hepatitis B flares in chronic hepatitis B patients receiving glucocorticoid pulse therapy
Ying-Cheng Lin et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2018)
Hepatitis B Virus-Specific CD8+T Cells Maintain Functional Exhaustion after Antigen Reexposure in an Acute Activation Immune Environment
Qin Wang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Management of anti-HBc-positive patients with rheumatic diseases treated with disease-modifying antirheumatic drugs-a single-center analysis of 2054 patients
Eva C. Schwaneck et al.
CLINICAL RHEUMATOLOGY (2018)
Recent Advances in HBV Reactivation Research
Lixia Guo et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Reactivation of hepatitis B virus infection in patients with rheumatoid arthritis receiving tofacitinib: a real-world study
Yi-Ming Chen et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan
Wataru Fukuda et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions
Rohit Loomba et al.
GASTROENTEROLOGY (2017)
Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation
Le-Feng Chen et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2017)
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Theo Vos et al.
LANCET (2017)
TIMELINE Managing rheumatic and musculoskeletal diseases - past, present and future
Gerd R. Burmester et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Sulfasalazine induces mitochondrial dysfunction and renal injury
Hossein Niknahad et al.
RENAL FAILURE (2017)
HBV DNA Integration: Molecular Mechanisms and Clinical Implications
Thomas Tu et al.
VIRUSES-BASEL (2017)
Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP
Joanne M. Donkers et al.
SCIENTIFIC REPORTS (2017)
Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis
Feliciano Chanana Paquissi
FRONTIERS IN IMMUNOLOGY (2017)
Phosphodiesterase 4 Inhibitors in Immune-mediated Diseases: Mode of Action, Clinical Applications, Current and Future Perspectives
Lazaros I. Sakkas et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Tocilizumab: A Review in Rheumatoid Arthritis
Lesley J. Scott
DRUGS (2017)
Abatacept: A Review in Rheumatoid Arthritis
Hannah A. Blair et al.
DRUGS (2017)
A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Hepatitis B Virus Reactivation Following Salazosulfapyridine Monotherapy in a Patient with Rheumatoid Arthritis
Kengo Akashi et al.
INTERNAL MEDICINE (2016)
Safety of Corticosteroid Treatment in Rheumatologic Patients With Markers of Hepatitis B Viral Infection Pilot Evaluation Study
Yolanda Braun-Moscovici et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2016)
Mechanisms of HBV-induced hepatocellular carcinoma
Massimo Levrero et al.
JOURNAL OF HEPATOLOGY (2016)
Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study
Valentina Varisco et al.
JOURNAL OF RHEUMATOLOGY (2016)
Requirements for global elimination of hepatitis B: a modelling study
Shevanthi Nayagam et al.
LANCET INFECTIOUS DISEASES (2016)
Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection
Melissa Padovan et al.
ARTHRITIS CARE & RESEARCH (2016)
Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
Ling-Hao Zhao et al.
NATURE COMMUNICATIONS (2016)
Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication
Christopher M. Murphy et al.
CELL REPORTS (2016)
Reactivation of hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs
Jun Nakamura et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2016)
Prevention of Hepatitis B reactivation in the setting of immunosuppression
Venessa Pattullo
CLINICAL AND MOLECULAR HEPATOLOGY (2016)
Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients
Xiangsheng Xu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Drug safety evaluation of apremilast for treating psoriatic arthritis
Swapna Busa et al.
EXPERT OPINION ON DRUG SAFETY (2015)
American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
K. Rajender Reddy et al.
GASTROENTEROLOGY (2015)
American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
Robert P. Perrillo et al.
GASTROENTEROLOGY (2015)
Recent US Food and Drug Administration Warnings on Hepatitis B Reactivation With Immune-Suppressing and Anticancer Drugs: Just the Tip of the Iceberg?
Adrian M. Di Bisceglie et al.
HEPATOLOGY (2015)
Safety of long-term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection
Michele Barone et al.
HEPATOLOGY (2015)
Long-term use of methotrexate does not result in hepatitis B reactivation in rheumatologic patients
Charlie Laohapand et al.
HEPATOLOGY INTERNATIONAL (2015)
HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase
Lise Riviere et al.
JOURNAL OF HEPATOLOGY (2015)
Interleukin 6 inhibits HBV entry through NTCP down regulation
Fidaa Bouezzedine et al.
VIROLOGY (2015)
Impaired Function of CD4+T Follicular Helper (Tfh) Cells Associated with Hepatocellular Carcinoma Progression
Yiqiong Jia et al.
PLOS ONE (2015)
IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome
Gianna Aurora Palumbo et al.
PLOS ONE (2015)
Severe infections in patients with autoimmune diseases treated with cyclophosphamide
Javier A. Cavallasca et al.
REUMATOLOGIA CLINICA (2015)
Discontinuation of antiviral prophylaxis correlates with high prevalence of hepatitis B virus (HBV) reactivation in rheumatoid arthritis patients with HBV carrier state: a real-world clinical practice
Ying-Qian Mo et al.
BMC MUSCULOSKELETAL DISORDERS (2014)
Viral-Human Chimeric Transcript Predisposes Risk to Liver Cancer Development and Progression
Chi-Chiu Lau et al.
CANCER CELL (2014)
Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy-a report of long-term follow-up of serial cases and literature review
Dandan Xuan et al.
CLINICAL RHEUMATOLOGY (2014)
Cyclosporin A and Its Analogs Inhibit Hepatitis B Virus Entry Into Cultured Hepatocytes Through Targeting a Membrane Transporter, Sodium Taurocholate Cotransporting Polypeptide (NTCP)
Koichi Watashi et al.
HEPATOLOGY (2014)
Hepatitis B Reactivation in Patients With Previous Hepatitis B Virus Exposure Undergoing Rituximab-Containing Chemotherapy for Lymphoma: A Prospective Study
Wai-Kay Seto et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
A review of methotrexate-associated hepatotoxicity
Roopjeet K. Bath et al.
JOURNAL OF DIGESTIVE DISEASES (2014)
Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications
Teresa Pollicino et al.
JOURNAL OF HEPATOLOGY (2014)
HBV Genotype C Strains With Spontaneous YMDD Mutations May be a Risk Factor for Hepatocellular Carcinoma
Jiahong Yang et al.
JOURNAL OF MEDICAL VIROLOGY (2014)
Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma
Y. M. Park et al.
JOURNAL OF VIRAL HEPATITIS (2014)
Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs
Shunsuke Mori
Modern Rheumatology (2014)
Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients
Yukitomo Urata et al.
Modern Rheumatology (2014)
Association of hepatitis B with antirheumatic drugs: a case–control study
Yasuo Oshima et al.
Modern Rheumatology (2014)
The BAFF/APRIL system in SLE pathogenesis
Fabien B. Vincent et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
IL-6 biology: implications for clinical targeting in rheumatic disease
Leonard H. Calabrese et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Hepatitis B reactivation following treatment with abatacept in a patient with past hepatitis B virus infection
Antonis Fanouriakis et al.
RHEUMATOLOGY (2014)
Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
Julie Lucifora et al.
SCIENCE (2014)
The Tudor Domain Protein Spindlin1 Is Involved in Intrinsic Antiviral Defense against Incoming Hepatitis B Virus and Herpes Simplex Virus Type 1
Aurelie Ducroux et al.
PLOS PATHOGENS (2014)
Prevalence of Past and Reactivated Viral Infections and Efficacy of Cyclosporine A as Monotherapy or in Combination in Patients with Psoriatic Arthritis-Synergy Study: A Longitudinal Observational Study
Delia Colombo et al.
BIOMED RESEARCH INTERNATIONAL (2014)
The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma
Pengyuan Yang et al.
NATIONAL SCIENCE REVIEW (2014)
HBV Reactivation in Patients Treated with Antitumor Necrosis Factor-Alpha (TNF-α)Agents for Rheumatic and Dermatologic Conditions: A Systematic Review and Meta-Analysis
Fabrizio Cantini et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2014)
Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection
Ioannnis Mitroulis et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Hepatitis B virus reactivation during therapy with ustekinumab for psoriasis in a hepatitis B surface-antigen-negative anti-HBs-positive patient
J. Koskinas et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C
H. -Y. Chiu et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Reduction of Hepatitis B Surface Antigen and Covalently Closed Circular DNA by Nucleos(t)ide Analogues of Different Potency
Danny Ka-Ho Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
FDA: Increased HBV Reactivation Risk With Ofatumumab or Rituximab
Mike Mitka
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Methyltransferase PRMT1 Is a Binding Partner of HBx and a Negative Regulator of Hepatitis B Virus Transcription
Shirine Benhenda et al.
JOURNAL OF VIROLOGY (2013)
Hepatitis B virus X (HBx) play an anti-apoptosis role in hepatic progenitor cells by activating Wnt/β-catenin pathway
Lihong Shen et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
Kinetic Profiles and Management of Hepatitis B Virus Reactivation in Patients With Immune-Mediated Inflammatory Diseases
Nina Droz et al.
ARTHRITIS CARE & RESEARCH (2013)
Rolipram Attenuates Bile Duct Ligation-Induced Liver Injury in Rats: A Potential Pathogenic Role of PDE4
Leila Gobejishvili et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection
Valentina Svicher et al.
ANTIVIRAL RESEARCH (2012)
Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus Pre-S2 mutants and its implication in hepatocarcinogenesis
Lily Hui-Ching Wang et al.
CARCINOGENESIS (2012)
The inhibitors of nucleotide biosynthesis leflunomide, FK778, and mycophenolic acid activate hepatitis B virus replication in vitro
Karin Hoppe-Seyler et al.
HEPATOLOGY (2012)
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis
Wei-Chih Tsai et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors
Cheng-Hao Huang et al.
JOURNAL OF HEPATOLOGY (2012)
Pivotal roles of the interleukin-23/T helper 17 cell axis in hepatitis B
Zemin Huang et al.
LIVER INTERNATIONAL (2012)
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma
Wing-Kin Sung et al.
NATURE GENETICS (2012)
Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer
Harrys A. Torres et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Management of the risk of hepatitis B virus reactivation in patients receiving immunosuppressive and immunomodulatory agents in internal medicine: Data from the REACTI-B survey and proposal for a management algorithm
B. Terrier et al.
REVUE DE MEDECINE INTERNE (2012)
Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication
Amanda J. Hodgson et al.
VIROLOGY (2012)
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
Huan Yan et al.
ELIFE (2012)
A fatal case of hepatitis B virus (HBV) reactivation during long-term, very-low-dose steroid treatment in an inactive HBV carrier
Joong Ho Bae et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2012)
Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy
Joung-Liang Lan et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
The clinical implications of hepatitis B virus genotype: Recent advances
Chih-Lin Lin et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Hepatitis B Virus Reactivation by Immunosuppressive Therapy in Patients with Autoimmune Diseases: Risk Analysis in Hepatitis B Surface Antigen-negative Cases
Masaru Kato et al.
JOURNAL OF RHEUMATOLOGY (2011)
Reactivation of Hepatitis B Virus After Steroid Treatment in Rheumatic Diseases
Jun Cheng et al.
JOURNAL OF RHEUMATOLOGY (2011)
Hepatitis B Virus (HBV) Reactivation in Patients Receiving Tumor Necrosis Factor (TNF)-Targeted Therapy Analysis of 257 Cases
Roberto Perez-Alvarez et al.
MEDICINE (2011)
Licensing Virus-Specific T Cells to Secrete the Neutrophil Attracting Chemokine CXCL-8 during Hepatitis B Virus Infection
Adam J. Gehring et al.
PLOS ONE (2011)
Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy
Maria Luisa Manzano-Alonso et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Lesson of the Week Life threatening myelotoxicity secondary to azathioprine in a patient with atopic eczema and normal thiopurine methyltransferase activity
Jamie S. Wee et al.
BRITISH MEDICAL JOURNAL (2011)
Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients
Sung-Nan Pei et al.
ANNALS OF HEMATOLOGY (2010)
Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection
D. Vassilopoulos et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective
Alan P. Venook et al.
ONCOLOGIST (2010)
Pathogenesis of hepatitis B virus infection
F. V. Chisari et al.
PATHOLOGIE BIOLOGIE (2010)
Risk of hepatitis B virus reactivation in patients with asthma or chronic obstructive pulmonary disease treated with corticosteroids
Tae-Wan Kim et al.
RESPIROLOGY (2010)
Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients
Sylvia Brost et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Safety of Tumor Necrosis Factor α Blockers in Hepatitis B Virus Occult Carriers (Hepatitis B Surface Antigen Negative/Anti-Hepatitis B Core Antigen Positive) With Rheumatic Diseases
R. Caporali et al.
ARTHRITIS CARE & RESEARCH (2010)
Blockade of Immunosuppressive Cytokines Restores NK Cell Antiviral Function in Chronic Hepatitis B Virus Infection
Dimitra Peppa et al.
PLOS PATHOGENS (2010)
The role of Interleukin 6 in the pathophysiology of rheumatoid arthritis
Srinivasan Srirangan et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2010)
Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature
K. Visser et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Not Interferon, but Interleukin-6 Controls Early Gene Expression in Hepatitis B Virus Infection
Marianna Hoesel et al.
HEPATOLOGY (2009)
Reactivation of Hepatitis B
Jay H. Hoofnagle
HEPATOLOGY (2009)
Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A
Da-Li Zheng et al.
JOURNAL OF HEPATOLOGY (2009)
Control of cccDNA function in hepatitis B virus infection
Massimo Levrero et al.
JOURNAL OF HEPATOLOGY (2009)
Reactivation of Hepatitis B Viral Infection in Inactive HBsAg Carriers Following Anti-Tumor Necrosis Factor-α Therapy
Soo-Jin Chung et al.
JOURNAL OF RHEUMATOLOGY (2009)
Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function
Laura Belloni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
HBV replication is significantly reduced by IL-6
Tzer-Min Kuo et al.
JOURNAL OF BIOMEDICAL SCIENCE (2009)
Hepatitis B reactivation after thalidomide
A. P. Grigg et al.
INTERNAL MEDICINE JOURNAL (2008)
Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection
Ih-Jen Su et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Effect of basal core promoter and pre-core mutations on hepatitis B virus replication
Saffie Jammeh et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Long-term tocilizumab therapy in a patient with rheumatoid arthritis and chronic hepatitis B
R. R. Raghavendran et al.
RHEUMATOLOGY (2008)
Chronic hepatitis B reactivation: a word of caution regarding the use of systemic glucocorticosteroid therapy
C-H. Yang et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection
Carolina Boni et al.
JOURNAL OF VIROLOGY (2007)
Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis
Hui-Ching Wang et al.
CANCER SCIENCE (2006)
Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies
L. H. Calabrese et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Observational study on efficacy, safety, and drug survival of anakinra in rheumatoid arthritis patients in clinical practice
A. A. den Broeder et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones
T Pollicino et al.
GASTROENTEROLOGY (2006)
The X protein of hepatitis B virus binds to the F box protein Skp2 and inhibits the ubiquitination and proteasomal degradation of c-Myc
N Kalra et al.
FEBS LETTERS (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients
A Wozniacka et al.
LUPUS (2006)
The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis
Jan Bondeson et al.
ARTHRITIS RESEARCH & THERAPY (2006)
HBV-induced carcinogenesis
Delphine Cougot et al.
JOURNAL OF CLINICAL VIROLOGY (2005)
Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection
AC Allison et al.
TRANSPLANTATION (2005)
Mechanisms of disease: Hepatitis B virus infection - Natural history and clinical consequences
D Ganem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma
HLY Chan et al.
GUT (2004)
Hepatic failure due to fibrosing cholestatic hepatitis in a patient with pre-surface mutant hepatitis B virus and mixed connective tissue disease treated with prednisolone and chloroquine
SA Zanati et al.
JOURNAL OF CLINICAL VIROLOGY (2004)
Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients:: need for primary prophylaxis
M Esteve et al.
GUT (2004)
Induction and regulation of IFNs during viral infections
L Malmgaard
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2004)
Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor κB, osteoprotegerin, and receptor activator of nuclear factor κB ligand
CK Lee et al.
ARTHRITIS AND RHEUMATISM (2004)
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
G Fattovich et al.
GASTROENTEROLOGY (2004)
Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator
KP Baker et al.
ARTHRITIS AND RHEUMATISM (2003)
Involvement of Crm1 in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles
M Forgues et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Genomic polymorphism within interleukin-1 family cytokines influences the outcome of septic patients
PG Ma et al.
CRITICAL CARE MEDICINE (2002)
Regulation of human B cell function by sulfasalazine and its metabolites
S Hirohata et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2002)
Structural organization of the hepatitis B virus minichromosome
CT Bock et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Synthesis and release of B-lymphocyte stimulator from myeloid cells
B Nardelli et al.
BLOOD (2001)
Ribavirin and mycophenolic acid potentiate the activity of guanine- and diaminopurine-based nucleoside analogues against hepatitis B virus
C Ying et al.
ANTIVIRAL RESEARCH (2000)
Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response
RKG Do et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
A B-cell receptor-specific selection step governs immature to mature B cell differentiation
MH Levine et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Mycophenolate mofetil and its mechanisms of action
AC Allison et al.
IMMUNOPHARMACOLOGY (2000)
Share Paper
